---
$id: https://graph.org.ai/products/commodity/51281625
$type: Product
source: UNSPSC
code: "51281625"
title: "Telavancin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Telavancin

**UNSPSC Code**: 51281625
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antibiotic with the molecular formula C80H106Cl2N11O27P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XK134822Z0, chemically known as vancomycin, n3-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)- but generally known as telavancin, which bears US NIH Compound Identifier 3081362. European Medicines Agency schedules Telavancin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26698. The term TELAVANCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, List 53). World Health Organization schedules telavancin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule telavancin under HS 29419000 and SITC 54139. As of Q4 2014, TELAVANCIN remains the US FDA Preferred Term for this commodity. Telavancin bears US NLM identifiers UMLS ID C1453642 and NCI Concept Code C87603. SMILES: Clc1c2Oc3c(OC4OC(C(O)C(O)C4OC4OC(C(O)C(NCCNCCCCCCCCCC)(C4)C)C)CO)c4Oc5c(Cl)cc(cc5)C(O)C(NC(=O)C(NC)CC(C)C)C(=O)NC(C(=O)NC(c(c3)c4)C(=O)NC3C(=O)NC(C(O)c(c1)cc2)C(=O)NC(c1c(c2cc3ccc2O)c(O)c(c(O)c1)CNCP(=O)(O)O)C(=O)O)CC(=O)N.

